General Information
Revision date
2010-04-26
Product name
Adenosine Injection, USP
Chemical name
6-amino-9-beta-D-ribofuranosyl-9H-purine
Icons in SDS
Company Information
company name
Sagent Pharmaceuticals, Inc
Section 2
SECTION 2: Hazards identification
Primary Physical Adenosine Injection is an anti-arrhythmic cardiac depressant that is used and Health in treating certain heart conditions. Minimal adverse effect should occur from routine use with this product. Acute signs and symptoms of exposure may include dizziness, nausea, vomiting, flushing of skin, irregular heartbeat, pain in chest, fluctuation in blood pressure and numbness or tingling in arms. May cause irritation to eyes, skin, and respiratory tract. Product may cause allergic reaction if inhaled or absorbed through the skin. Adenosine has low chronic toxicity.
Principle Routes of Exposure
Adenosine Injection may be absorbed via contact with skin or eyes; inhalation of aerosols or accidentally ingested. Under normal use with supervision of a physician, Adenosine Injection presents little hazard. 2 of 8 Signs & Symptoms Exposure can cause dilation of the blood vessels and an increase in of Exposure: contraction of some smooth muscles. Chemical Listed as NTP No IARC No OSHA No Carcinogen:
Medical Conditions Generally Aggravated by Exposure
Adenosine is a mild bronchoconstrictor and should be used with caution in asthmatic patients. Adenosine is contraindicated in patients with second-degree or third-degree atrioventricular (AV) block or sick sinus syndrome, except where a pacemaker has been placed. See package insert for additional information.
